Difference between revisions of "Gautret P, et al, Int J Antimicrob Agents (2020), cited as Ref 82 in DOI:10.1007/s11886-020-01292-3 (Q10591)"
Jump to navigation
Jump to search
(Created claim: Fourth Author string (P152): Hoang VT, #quickstatements; #temporary_batch_1592503336917) |
(Created claim: Fifth Author string (P153): Meddeb L, #quickstatements; #temporary_batch_1592503455634) |
||
| Property / Fifth Author string | |||
| + | Meddeb L | ||
| Property / Fifth Author string: Meddeb L / rank | |||
| + | Normal rank | ||
Revision as of 18:06, 18 June 2020
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Gautret P, et al, Int J Antimicrob Agents (2020), cited as Ref 82 in DOI:10.1007/s11886-020-01292-3
|
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
|
Statements
Q10356 (Deleted Item)
0 references
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial;105949. (English)
0 references
Gautret P
0 references
Lagier J-C
0 references
Parola P
0 references
Hoang VT
0 references
Meddeb L
0 references
